Antimicrobial peptide exposure selects for Staphylococcus aureus resistance to human defence peptides

Background: The clinical development of antimicrobial peptides (AMPs) is currently under evaluation to combat the rapid increase in MDR bacterial pathogens. However, many AMPs closely resemble comp ...